Check-Cap (NASDAQ:MBAI) Trading 0.2% Higher – Here’s What Happened

Check-Cap Ltd (NASDAQ:MBAI) was up 0.2% on Thursday . The company traded as high as $6.45 and last traded at $6.34. 3,181 shares changed hands during mid-day trading, a decline of 89% from the average session volume of 29,708 shares. The stock had previously closed at $6.33.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Check-Cap in a research report on Tuesday, July 21st. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has an average rating of “Sell”.

Check-Cap Trading Up 0.8%

The company has a 50 day moving average of $7.46 and a 200 day moving average of $9.80. The firm has a market cap of $8.82 million, a price-to-earnings ratio of -0.45 and a beta of 0.67.

Check-Cap Company Profile

Check-Cap Ltd. was an Israel-based medical diagnostics company focused on developing noninvasive technologies for colorectal cancer screening. Its lead product, C-Scan, was an ingestible, capsule-based imaging system designed to examine the colon for polyps and other abnormalities without requiring the extensive bowel preparation typically associated with conventional colonoscopy.

The C-Scan system was intended to combine a disposable capsule with an external tracking and data-collection system, allowing physicians to review images of the gastrointestinal tract after the capsule passed through the body.